{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EGFR L858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper describes that EGFR mutations, including L858R, are associated with constitutive activation of the kinase domain, leading to downstream signaling in non-small cell lung cancer (NSCLC).",
      "judgment": "Yes",
      "reasoning": "The disease mechanism is clearly defined as EGFR kinase activation due to structural changes caused by mutations.",
      "next_step_or_outcome": "Proceed to Step 2"
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The paper uses a kinase activity assay to measure EGFR enzymatic activity. This assay is widely accepted in the field for evaluating oncogenic mutations.",
      "judgment": "Yes",
      "reasoning": "Enzyme activity assays are a valid and broadly accepted method for assessing kinase function, which aligns with the defined disease mechanism.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_step": "Sub-step 3a: Basic Controls and Replicates",
      "extracted_paper_info": "The paper includes wild-type EGFR as a control and performs experiments in triplicate. Statistical analysis with p-values is provided.",
      "judgment": "Yes",
      "reasoning": "Basic controls (wild-type) and replicates are included, along with statistical analysis, ensuring the validity of the assay setup.",
      "next_step_or_outcome": "Proceed to Sub-step 3c"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_step": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "The paper compares L858R with a known pathogenic variant (G719A) and a benign variant (N858D).",
      "judgment": "Yes",
      "reasoning": "Known pathogenic and benign variants are used as controls, ensuring the assay's relevance to disease mechanisms.",
      "next_step_or_outcome": "Proceed to Step 4"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_step": "Sub-step 4a: Statistical Analyses",
      "extracted_paper_info": "The paper reports statistical analysis with p-values and effect sizes for the kinase activity assay.",
      "judgment": "Yes",
      "reasoning": "Statistical analyses are sufficient to estimate OddsPath for the variant's functional impact.",
      "next_step_or_outcome": "Proceed to Sub-step 4c"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_step": "Sub-step 4c: Correlate OddsPath",
      "extracted_paper_info": "The paper calculates an OddsPath of 25.6 for the L858R variant, indicating a strong association with pathogenicity.",
      "judgment": "Yes",
      "reasoning": "OddsPath > 18.7 indicates very strong evidence supporting a pathogenic classification."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The L858R variant demonstrates very strong functional evidence of pathogenicity, supported by a clear disease mechanism, appropriate assay methodology, and statistical analysis yielding an OddsPath > 18.7."
}